Ticker > Company >

Denis Chem Lab share price

Denis Chem Lab Ltd.

BSE: 537536 SECTOR: Pharmaceuticals & Drugs  14k   25   1

102.00
+2.00 (2.00%)
BSE: Today, 12:14 PM

Price Summary

Today's High

₹ 102

Today's Low

₹ 97

52 Week High

₹ 232.9

52 Week Low

₹ 87.99

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

141.54 Cr.

Enterprise Value

117.91 Cr.

No. of Shares

1.39 Cr.

P/E

14.02

P/B

1.68

Face Value

₹ 10

Div. Yield

2.5 %

Book Value (TTM)

₹  60.7

CASH

24.67 Cr.

DEBT

1.05 Cr.

Promoter Holding

38.98 %

EPS (TTM)

₹  7.28

Sales Growth

4.34%

ROE

14.62 %

ROCE

20.15%

Profit Growth

41.93 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Denis Chem Lab Ltd.

AquaPulse

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year4.34%
3 Year15.36%
5 Year6.22%

Profit Growth

1 Year41.93%
3 Year70.16%
5 Year11.93%

ROE%

1 Year14.62%
3 Year11.91%
5 Year9.36%

ROCE %

1 Year20.15%
3 Year16.67%
5 Year13.57%

Debt/Equity

0.013

Price to Cash Flow

8.04

Interest Cover Ratio

28.8575

CFO/PAT (5 Yr. Avg.)

2.27840916396024

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 38.98 0.00
Dec 2024 38.98 0.00
Sep 2024 38.98 0.00
Jun 2024 38.98 0.00
Mar 2024 38.98 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 70.1567536129833% for the Past 3 years.
  • The company has shown a good revenue growth of 15.3595726103425% for the Past 3 years.
  • The company has significantly decreased its debt by 0.8876 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 28.8575.
  • Company’s PEG ratio is 0.334249794932016.
  • The company has an efficient Cash Conversion Cycle of 6.01320000000001 days.
  • Company has a healthy liquidity position with current ratio of 2.5509.
  • The company has a good cash flow management; CFO/PAT stands at 2.27840916396024.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.55369024187732.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Net Sales 40.06 39.86 41.26 47.82 42.84
Total Expenditure 34.07 34.78 36.91 41.93 39.02
Operating Profit 5.99 5.08 4.35 5.88 3.82
Other Income 0.26 0.6 0.33 0.58 0.3
Interest 0.13 0.24 0.12 0.09 0.07
Depreciation 1.84 1.75 1.63 1.66 1.84
Exceptional Items 0 0 0 0 0
Profit Before Tax 4.28 3.69 2.92 4.71 2.22
Tax 1.08 0.96 0.85 1.18 0.46
Profit After Tax 3.2 2.73 2.08 3.53 1.76
Adjusted EPS (Rs) 2.31 1.97 1.5 2.54 1.27

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 136.15 109.32 136.56 160.85 167.82
Total Expenditure 121.15 99.06 122.21 142.07 146.59
Operating Profit 15 10.25 14.35 18.78 21.23
Other Income 0.28 0.35 1.05 0.59 1.39
Interest 2.89 1.55 0.76 0.64 0.54
Depreciation 6.66 5.96 5.76 7.82 6.95
Exceptional Items 0 0 0 0 0
Profit Before Tax 5.73 3.09 8.88 10.92 15.13
Tax 1.51 0.82 2.62 3.06 3.98
Net Profit 4.21 2.26 6.26 7.86 11.16
Adjusted EPS (Rs.) 3.04 1.63 4.51 5.66 8.04

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 13.88 13.88 13.88 13.88 13.88
Total Reserves 45.21 47.63 52.57 58.39 66.49
Borrowings 2.17 3.5 2.18 0.92 0.45
Other N/C liabilities 1.79 2.16 2.46 2.19 1.34
Current liabilities 34.36 25.1 25.31 24.08 27.2
Total Liabilities 97.42 92.26 96.39 99.45 109.35
Assets
Net Block 45.84 41.39 41.66 35.42 37.62
Capital WIP 0 0.08 0 2.13 0.22
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 1.54 2.24 1.41 2.66 2.13
Other N/C Assets 0 0 0 0 0
Current Assets 50.04 48.55 53.32 59.24 69.37
Total Assets 97.42 92.26 96.39 99.45 109.35
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 5.73 3.09 8.88 10.92 15.13
Adjustment 9.32 7.2 5.91 8.04 5.84
Changes in Assets & Liabilities 0.08 -1.59 3.36 -0.22 0.97
Tax Paid -1.75 -0.72 -1.08 -2.39 -4.34
Operating Cash Flow 13.37 7.97 17.07 16.34 17.6
Investing Cash Flow -1.98 -1.13 -10.14 -11.15 -14.68
Financing Cash Flow -13.9 -5.51 -7.2 -4.01 -4.21
Net Cash Flow -2.51 1.33 -0.27 1.18 -1.29

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 38.98 38.98 38.98 38.98 38.98
anar himanshu patel 21.70 21.70 21.70 21.70 21.70
himanshu chaitanya patel 14.76 14.76 14.76 14.76 14.76
nirmal himanshu patel 2.52 2.52 2.52 2.52 2.52
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 61.02 61.02 61.02 61.02 61.02
llp 0.04 0.06 0.06 0.06 0.06
own infracon private limi... 11.50 10.99 10.59 10.58 10.55
v-s holding b.v. 20.74 20.74 20.74 20.74 20.74
varun daga 11.50 10.98 9.72 9.64 9.64

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Denis Chem Lab - Quaterly Results 14 Feb, 2:57 PM Denis Chem Lab - Quaterly Results 14 Feb, 2:57 PM Denis Chem Lab informs about board meeting 29 Oct, 5:18 PM Denis Chem Lab informs about loss of share certificate 26 Oct, 11:54 AM Denis Chem Lab submits AGM and annual report 17 Aug, 2:26 PM Denis Chem Lab informs about AGM and annual report 17 Aug, 2:13 PM Denis Chem Lab - Quaterly Results 14 Aug, 2:27 PM Denis Chem Lab - Quaterly Results 14 Aug, 2:27 PM Denis Chem Lab informs about press release 31 Jul, 3:07 PM Denis Chem Lab - Quaterly Results 28 May, 2:28 PM Denis Chem Lab - Quaterly Results 28 May, 2:28 PM Denis Chem Lab informs about PCS certificate 12 Apr, 4:01 PM Denis Chem Lab - Quaterly Results 14 Feb, 1:58 PM Denis Chem Lab - Quaterly Results 14 Feb, 1:58 PM Denis Chem Lab informs about loss of share certificate 30 Jan, 5:01 PM Denis Chem Lab informs about loss of share certificate 5 Jan, 5:13 PM Denis Chem Lab - Quaterly Results 7 Nov, 3:26 PM Denis Chem Lab - Quaterly Results 7 Nov, 3:26 PM Denis Chem Lab informs about newspapers advertisement 25 Aug, 3:00 PM Denis Chem Lab - Quaterly Results 14 Aug, 1:56 PM Denis Chem Lab informs about closure of trading window 27 Jun, 5:07 PM Denis Chem Lab submits board meeting intimation 16 May, 12:42 PM Denis Chem Lab - Quaterly Results 14 Feb, 12:21 PM Denis Chem Lab - Quaterly Results 10 Aug, 2:54 PM Denis Chem Lab informs about board meeting intimation 1 Aug, 2:35 PM Denis Chem Lab submits newspapers advertisement 22 Jul, 4:55 PM Denis Chem Lab - Quaterly Results 26 May, 1:12 PM Denis Chem Lab - Quaterly Results 26 May, 1:12 PM Denis Chem Lab informs about board meeting intimation 6 May, 2:49 PM Denis Chem Lab informs about closure of trading window 26 Mar, 3:55 PM Denis Chem Lab - Quaterly Results 12 Feb, 1:08 PM Denis Chem Lab informs about board meeting 29 Jan, 2:35 PM Denis Chem informs about loss of share certificate 24 Dec, 4:29 PM Denis Chem Lab informs about closure of trading window 28 Jun, 5:16 PM Denis Chem Lab informs about certificate 8 Oct, 4:25 PM Denis Chem Lab informs about clarification on price movement 4 Apr, 11:29 AM

Denis Chem Lab Stock Price Analysis and Quick Research Report. Is Denis Chem Lab an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Denis Chem Lab and its performance over the period of time. Denis Chem Lab stock price today is Rs 102.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Denis Chem Lab cash from the operating activity was Rs 17.6035 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Denis Chem Lab has a Debt to Equity ratio of 0.013 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Denis Chem Lab , the EPS growth was 41.935 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Denis Chem Lab has OPM of 12.6522148466828 % which is a bad sign for profitability.
     
  • ROE: Denis Chem Lab have a average ROE of 14.6181 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Denis Chem Lab is Rs 102. One can use valuation calculators of ticker to know if Denis Chem Lab share price is undervalued or overvalued.
Last Updated on:
Brief about Denis Chem Lab
X